BIOMAT Database Logo BIOMAT Database Logo

[Cardiovascular manifestations in systemic scleroderma]. 1997

A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
Hôpital de Dantec, Service de Cardiologie, Dakar, Sénégal.

OBJECTIVE Patients with systemic scleroderma often have latent heart disease which could play an important role in morbidity and mortality. We therefore conducted a prospective study of cardiovascular manifestations in patients with systemic scleroderma. METHODS A prospective cross-sectional study included 29 patients with systemic scleroderma who underwent a complete cardiovascular work-up including physical examination, electrocardiogram, chest x-ray and Doppler-echocardiogram from July 1993 to February 1996. RESULTS Hypertension was observed in 6 patients (20.7%) and was positively correlated with age (p = 0.007). Raynaud syndrome was also found in 6 patients (20.6%). Heart disease was observed in 14 patients (48.3%) and was positively correlated with age and lack of treatment for scleroderma (p = 0.008). Myocardial disease was the most frequent (11 patients, 37.9%), followed by pericardial disease and valve disease (4 cases each, 13.8%). Rhythm and conduction disorders were found in 2 (6.9%) and 8 (27.6%) of the patients. CONCLUSIONS Cardiovascular manifestations are frequent but often latent in patients with systemic scleroderma. This finding emphasizes the importance of routine cardiovascular work-up in all patients with scleroderma.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D010493 Pericarditis Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS. Pleuropericarditis
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females

Related Publications

A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
The cardiovascular manifestations of systemic sclerosis (scleroderma).
May 1986, Current problems in cardiology,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
Systemic manifestations in localized scleroderma.
December 2004, Current rheumatology reports,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Digestive manifestations during systemic scleroderma].
January 1989, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Systemic scleroderma and neurologic manifestations].
January 1991, Annales de dermatologie et de venereologie,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Vascular manifestations in systemic sclerosis (scleroderma)].
May 1998, Minerva medica,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
Neurological manifestations in systemic sclerosis (scleroderma).
August 1984, The Journal of rheumatology,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Progressive systemic sclerosis (scleroderma). Gastrointestinal manifestations].
September 1982, Ugeskrift for laeger,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Progressive systemic sclerosis (scleroderma): oral manifestations].
January 1990, Archivio stomatologico,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
[Osteoarticular manifestations in children with systemic scleroderma].
January 1975, Vestnik rentgenologii i radiologii,
A Kane, and A Kane, and S A Ba, and F Barry, and M T Dieng, and M Sarr, and P Diousse, and I B Diop, and F Ly, and L Hane, and S O Niang, and N B Ndiaye, and B Ndiaye, and S M Diouf
Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma).
November 1993, Muscle & nerve,
Copied contents to your clipboard!